Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver

BACKGROUND: CETP is a plasma protein that modulates atherosclerosis risk through its HDL-cholesterol reducing action. The aim of this work was to examine the effect of the PPARα agonist, ciprofibrate, on the CETP gene expression, in the presence and absence of apolipoprotein (apo) CIII induced hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Bighetti, Eliete JB, Patrício, Patrícia R, Casquero, Andrea C, Berti, Jairo A, Oliveira, Helena CF
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784759/
https://www.ncbi.nlm.nih.gov/pubmed/19930639
http://dx.doi.org/10.1186/1476-511X-8-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784759/
https://www.ncbi.nlm.nih.gov/pubmed/19930639
http://dx.doi.org/10.1186/1476-511X-8-50

Ejemplares similares